10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q3 2014

Filing Information

Form Type	10-Q
Accession Number	`0000946644-14-000030`
Period End Date	20140930
Filing Date	20141107
Fiscal Year	2014
Fiscal Period	Q3
XBRL Instance	heb-20140930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 73 Cash Flow Statement 58 Stockholders Equity 11

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.60M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$16.17M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$17.39M	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$235.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$358.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$18.55M	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$17.67M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.72M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	193.71M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	168.66M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.05M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.08M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	193.71M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$853.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	168.66M	shares	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$7.05M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$7.27M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$136.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$134.00K	USD	Point-in-time
Total assets	`Assets`	$31.87M	USD	Point-in-time
Total assets	`Assets`	$30.64M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.45M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.27M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.23M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.78M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$33.00K	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$29.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.26M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.53M	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$23.00K	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$3.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$13.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$14.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$4.27M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.57M	USD	Point-in-time
Commitments and contingencies (Notes 6, 8, 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 6, 8, 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 193,708,424 and 168,660,370, respectively	`CommonStockValue`	$168.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 193,708,424 and 168,660,370, respectively	`CommonStockValue`	$194.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$299.60M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$289.56M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-114.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-114.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-273.31M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-260.32M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.30M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.36M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$31.87M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$30.64M	USD	Point-in-time

Income Statement 73 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`SalesRevenueGoodsNet`	$45.00K	USD	1 Quarter
Clinical treatment programs	`SalesRevenueGoodsNet`	$114.00K	USD	3 Qtrs
Clinical treatment programs	`SalesRevenueGoodsNet`	$157.00K	USD	3 Qtrs
Clinical treatment programs	`SalesRevenueGoodsNet`	$36.00K	USD	1 Quarter
Total revenues	`Revenues`	$36.00K	USD	1 Quarter
Total revenues	`Revenues`	$45.00K	USD	1 Quarter
Total revenues	`Revenues`	$157.00K	USD	3 Qtrs
Total revenues	`Revenues`	$114.00K	USD	3 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$252.00K	USD	1 Quarter
Production/cost of goods sold	`CostOfRevenue`	$306.00K	USD	1 Quarter
Production/cost of goods sold	`CostOfRevenue`	$1.08M	USD	3 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$923.00K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.17M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$6.83M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.89M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$6.55M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.17M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.07M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.21M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.96M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$4.50M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$13.87M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$14.68M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$4.37M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-14.53M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-13.76M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-4.46M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.33M	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$4.00K	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$3.00K	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$9.00K	USD	3 Qtrs
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$14.00K	USD	3 Qtrs
Interest and other income	`OtherInterestAndDividendIncome`	$89.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$130.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$414.00K	USD	3 Qtrs
Interest and other income	`OtherInterestAndDividendIncome`	$624.00K	USD	3 Qtrs
Other than temporary impairment loss on marketable securities	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	-	USD	3 Qtrs
Other than temporary impairment loss on marketable securities	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	$800.00K	USD	1 Quarter
Other than temporary impairment loss on marketable securities	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	$800.00K	USD	3 Qtrs
Other than temporary impairment loss on marketable securities	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	-	USD	1 Quarter
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	-	USD	1 Quarter
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.13M	USD	Point-in-time
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$686.00K	USD	3 Qtrs
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	-	USD	1 Quarter
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.13M	USD	3 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$229.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$38.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$1.00K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-5.14M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.03M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-12.99M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-4.20M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-848.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-169.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$197.00K	USD	1 Quarter
Reclassification adjustments for impairment losses included in net loss	`OtherthanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentAvailableforsaleSecuritiesNetofTax`	-	USD	3 Qtrs
Reclassification adjustments for impairment losses included in net loss	`OtherthanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentAvailableforsaleSecuritiesNetofTax`	$800.00K	USD	1 Quarter
Reclassification adjustments for impairment losses included in net loss	`OtherthanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentAvailableforsaleSecuritiesNetofTax`	-	USD	1 Quarter
Reclassification adjustments for impairment losses included in net loss	`OtherthanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentAvailableforsaleSecuritiesNetofTax`	$800.00K	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-12.99M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.14M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.37M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-13.08M	USD	3 Qtrs
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	3 Qtrs
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	3 Qtrs
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	190.68M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	167.14M	shares	3 Qtrs
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	184.43M	shares	3 Qtrs
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	167.39M	shares	1 Quarter

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-5.14M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.03M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-12.99M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-4.20M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$500.00K	USD	3 Qtrs
Depreciation of property and equipment	`Depreciation`	$504.00K	USD	3 Qtrs
Amortization and abandonment of patent and trademark rights	`AdjustmentForAmortization`	$144.00K	USD	3 Qtrs
Amortization and abandonment of patent and trademark rights	`AdjustmentForAmortization`	$414.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$229.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$38.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$1.00K	USD	3 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$260.00K	USD	3 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$292.00K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	-	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-453.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$10.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-123.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.21M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-197.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.57M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$553.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.65M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.93M	USD	3 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$386.00K	USD	3 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$747.00K	USD	3 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$184.00K	USD	3 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$187.00K	USD	3 Qtrs
Deposits on capital leases refunded	`ProceedsfromRefundedCapitalLeaseDeposits`	$3.00K	USD	3 Qtrs
Deposits on capital leases refunded	`ProceedsfromRefundedCapitalLeaseDeposits`	$2.00K	USD	3 Qtrs
Deposit paid on office lease	`PaymentsforOfficeLeaseDeposits`	-	USD	3 Qtrs
Deposit paid on office lease	`PaymentsforOfficeLeaseDeposits`	$74.00K	USD	3 Qtrs
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.22M	USD	3 Qtrs
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$14.07M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$13.07M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$651.00K	USD	3 Qtrs
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$36.00K	USD	3 Qtrs
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$24.00K	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$9.76M	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-36.00K	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.74M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-614.00K	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$459.00K	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.26M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.60M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.26M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.60M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Issuance of common stock for accounts payable	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$38.00K	USD	3 Qtrs
Issuance of common stock for accounts payable	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$237.00K	USD	3 Qtrs
Unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	3 Qtrs
Unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-93.00K	USD	3 Qtrs
Cash paid for interest expense and capitalized construction interest	`InterestPaid`	$-9.00K	USD	3 Qtrs
Cash paid for interest expense and capitalized construction interest	`InterestPaid`	$-144.00K	USD	3 Qtrs

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.30M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.36M	USD	Point-in-time
Stock issued for settlement of accounts payable	`StockIssuedForSettlementOfAccountsPayable`	$38.00K	USD	3 Qtrs
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$292.00K	USD	3 Qtrs
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$260.00K	USD	3 Qtrs
Stock sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$9.76M	USD	3 Qtrs
Net comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-12.99M	USD	3 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.30M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.36M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.